MPH.V - Medicure Inc.

TSXV - TSXV Delayed Price. Currency in CAD
8.13
-0.02 (-0.25%)
At close: 2:19PM EDT
Stock chart is not supported by your current browser
Previous Close8.15
Open8.09
Bid8.01 x 0
Ask8.50 x 0
Day's Range8.09 - 8.13
52 Week Range5.48 - 10.67
Volume1,506
Avg. Volume13,940
Market Cap128.21M
Beta0.61
PE Ratio (TTM)5.95
EPS (TTM)1.37
Earnings DateNov 7, 2017 - Nov 13, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.75
  • How Did Medicure Inc’s (TSXV:MPH) 107.77% ROE Fare Against The Industry?
    Simply Wall St.19 days ago

    How Did Medicure Inc’s (TSXV:MPH) 107.77% ROE Fare Against The Industry?

    With an ROE of 107.77%, Medicure Inc (TSXV:MPH) outpaced its own industry which delivered a less exciting 12.35% over the past year. On the surface, this looks fantastic since weRead More...

  • ACCESSWIRE19 days ago

    Today's Research Reports on Advanced Proteome Therapeutics, Cronos Group, Medicure and Helix BioPharma

    NEW YORK, NY / ACCESSWIRE / October 4, 2017 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • CNW Group20 days ago

    IIROC Trading Resumption - MPH

    IIROC Trading Resumption - MPH

  • PR Newswire20 days ago

    IIROC Trading Resumption - MPH

    VANCOUVER , Oct. 3, 2017 /CNW/ - Trading resumes in: Company: Medicure Inc. TSX-Venture Symbol: MPH Resumption (ET): 9:45 AM IIROC can make a decision to impose a temporary suspension (halt) of trading ...

  • Newsfile20 days ago

    IIROC Trade Resumption - Medicure Inc.

    Vancouver, British Columbia--(Newsfile Corp. - October 3, 2017) - Trading resumes in: Company: Medicure Inc. TSX-V Symbol: MPH ...

  • PR Newswire20 days ago

    Medicure Announces Sale of Apicore Business

    WINNIPEG, Oct. 3, 2017 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, today announced that it has sold its interests in Apicore to an arm's length, pharmaceutical company (the "Buyer"). Medicure acquired Apicore in a series of transactions occurring between July 3, 2014 and July 12, 2017 and had obtained a CDN$60 million loan towards these purchases. Under the transaction, Medicure will receive net proceeds of approximately US$105 million.

  • CNW Group20 days ago

    Medicure Announces Sale of Apicore Business

    Medicure Announces Sale of Apicore Business

  • PR Newswire21 days ago

    IIROC Trading Halt - MPH

    VANCOUVER , Oct. 2, 2017 /CNW/ - The following issues have been halted by IIROC: Company: Medicure Inc. TSX-Venture Symbol: MPH Reason: At the Request of the Company Pending News Halt Time (ET): 10:22 ...

  • Newsfile21 days ago

    IIROC Trade Halt - Medicure Inc.

    Vancouver, British Columbia--(Newsfile Corp. - October 2, 2017) - The following issues have been halted by IIROC: Company:  Medicure Inc. TSX-V Symbol: MPH ...

  • Medicure, Inc. :MPH-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 9, 2017
    Capital Cube2 months ago

    Medicure, Inc. :MPH-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 9, 2017

    Categories: Yahoo FinanceGet free summary analysis Medicure, Inc. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of CAD 20.34 million, Net Earnings of CAD 1.36 million. Gross margins narrowed from 88.76% to 60.13% compared to the same period last year, operating (EBITDA) margins now 30.21% from 14.39%. Change in operating cash ... Read more (Read more...)

  • CNW Group2 months ago

    Buffalo Capital Inc. Announces Its Qualifying Transaction and a Concurrent Financing

    Buffalo Capital Inc. Announces Its Qualifying Transaction and a Concurrent Financing

  • Associated Press3 months ago

    Medicure posts 2Q profit

    On a per-share basis, the Winnipeg, Manitoba-based company said it had profit of 6 cents. The drugmaker posted revenue of $15.1 million in the period. Medicure shares have fallen 21 percent since the beginning ...

  • PR Newswire3 months ago

    Medicure Reports Financial Results for Quarter Ended June 30, 2017

    WINNIPEG , Aug. 7, 2017 /PRNewswire/ - Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, today reported its results from operations ...

  • CNW Group3 months ago

    Medicure Reports Financial Results for Quarter Ended June 30, 2017

    Medicure Reports Financial Results for Quarter Ended June 30, 2017

  • Medicure, Inc. :MPH-CA: Earnings Analysis: Q1, 2017 By the Numbers : August 3, 2017
    Capital Cube3 months ago

    Medicure, Inc. :MPH-CA: Earnings Analysis: Q1, 2017 By the Numbers : August 3, 2017

    Categories: Yahoo FinanceGet free summary analysis Medicure, Inc. reports financial results for the quarter ended March 31, 2017. Highlights Summary numbers: Revenues of CAD 8.71 million, Net Earnings of CAD -5.08 million. Gross margins narrowed from 85.57% to 40.80% compared to the same period last year, operating (EBITDA) margins now -17.68% from 27.36%. Change in operating cash ... Read more (Read more...)

  • PR Newswire3 months ago

    Medicure Q2 Results and Conference Call Dates

    WINNIPEG , Aug. 2, 2017 /PRNewswire/ - Medicure Inc. (" Medicure ") (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, will release financial results for the second quarter on Monday, ...

  • CNW Group3 months ago

    Medicure Q2 Results and Conference Call Dates

    Medicure Q2 Results and Conference Call Dates

  • CNW Group3 months ago

    Medicure Closes Acquisition of Additional Interests in Apicore

    Medicure Closes Acquisition of Additional Interests in Apicore

  • PR Newswire3 months ago

    Medicure Closes Acquisition of Additional Interests in Apicore

    WINNIPEG, July 12, 2017 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a leading Canadian specialty pharmaceutical company, is pleased to announce that it has closed the acquisition of additional interests in Apicore Inc. and Apicore LLC (together "Apicore") from Apicore's founding shareholders as previously announced on July 10, 2017.  The acquisition, for US$24.5 million, represents approximately 32% of the fully diluted ownership of Apicore and brings Medicure's ownership in Apicore Inc. to approximately 98% (94% on a fully diluted basis). Medicure's initial ownership interest and option rights in Apicore were obtained for its lead role in structuring and participating in a majority interest purchase and financing of Apicore that occurred on July 3, 2014.  Medicure acquired a majority interest in Apicore through the exercise of its option rights on December 1, 2016.

  • CNW Group3 months ago

    Medicure Exercises Option to Acquire Additional Interests in Apicore

    Medicure Exercises Option to Acquire Additional Interests in Apicore

  • PR Newswire3 months ago

    Medicure Exercises Option to Acquire Additional Interests in Apicore

    WINNIPEG, July 10, 2017 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a leading Canadian specialty pharmaceutical company, is pleased to announce that it and its wholly owned Mauritius subsidiary have exercised their option (the "Option") to acquire additional interests in Apicore Inc. and Apicore LLC (together "Apicore") from Apicore's founding shareholders.  The Option exercise allows for the acquisition of all of the shares of Apicore Inc. and Apicore LLC held by the founding shareholders (representing approximately 32% of the fully diluted ownership of Apicore) for US$24.5 million, being the price provided for under the Option. This acquisition brings Medicure's ownership in Apicore Inc. to approximately 98% (94% on a fully diluted basis).  Medicure expects to close the acquisition by July 14, 2017.

  • CNW Group4 months ago

    Medicure Provides Update on Apicore Purchase Option

    Medicure Provides Update on Apicore Purchase Option

  • PR Newswire4 months ago

    Medicure Provides Update on Apicore Purchase Option

    WINNIPEG, July 3, 2017 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a leading Canadian specialty pharmaceutical company, announced today that the Company's option (the "Option") to acquire additional shares in Apicore, which otherwise would have expired today, has been extended.  The Option covers an additional minority interest in Apicore (the "Minority Interest") currently representing approximately 32% of the fully diluted shares of Apicore.  The Minority Interest is held by Apicore's founding shareholders.  Medicure currently owns approximately 62% of the fully diluted shares of Apicore. Notwithstanding the foregoing, there can be no assurance that any acquisition by the Company of additional shares of Apicore will occur.

  • Associated Press5 months ago

    Medicure reports 1Q loss

    The Winnipeg, Manitoba-based company said it had a loss of 25 cents per share. The drugmaker posted revenue of $6.6 million in the period. Medicure shares have dropped 33 percent since the beginning of ...